By Lavenhill Securities Limited The announcement of Phoenix Sky Harbor International Airport's (PHX) first-ever nonstop flight to Asia is a major milestone, according to Lavenhill Securities Limited, a prominent financial advice business.
|
By Lavenhill Securities Limited Following Pfizer's announcement of a transaction for up to $6 billion, Lavenhill Securities Limited, a major global healthcare and pharmaceutical investment research firm, released a full analysis of the situation.
|
By Lavenhill Securities Limited Lavenhill Securities Limited, a leading market analysis and investment advisory firm, today reported that Palantir Technologies Inc. closed at an all-time high
|
By Lavenhill Securities Limited Lavenhill Securities Limited has released a new evaluation of Uber Technologies Inc. in light of the company's recently announced policy shift to reduce remote work and increase in-office presence.
|
By Lavenhill Securities Limited Lavenhill Securities Limited has released a detailed market update revealing that Honeywell International Inc. has reached a historic milestone, with its stock hitting an all-time high following strong Q1 2025 results.
|
By Lavenhill Securities Limited Lavenhill Securities has recently published a new market analysis that emphasizes the recent announcement that retail trading platform eToro has filed for its U.S. initial public offering (IPO).
|
By Lavenhill Securities Limited The incredible success of OpenAI's most recent investment round—which has garnered a total of $40 billion—is being keenly watched by Lavenhill Securities Limited.
|
By Lavenhill Securities Limited JPMorgan said that holiday sales exceeded analysts' projections despite an improved consumer spending environment.
|
By Lavenhill Securities Limited President Brad Smith said Friday in a blog post that Microsoft would invest $80 billion on data centers to train and operate AI by the end of the fiscal year.
|
By Lavenhill Securities Limited Global Payments reported second-quarter revenue that exceeded expectations but fell slightly short on earnings.
|
By Lavenhill Securities Limited RayzeBio Inc. (RYZB) shares soared Tuesday after Bristol Myers Squibb Co. (BMY) announced a $4.1 billion acquisition of the radiopharmaceutical therapy business to extend its cancer treatment choices.
|